The project in a nutshell
Testing whether a protein drug called FAB4 can make the body's
own immune system attack prostate cancer cells.
Why we funded it
If successful, FAB4-guided immunotherapy could provide a new
treatment for men affected by advanced and otherwise untreatable
prostate cancer, helping to improve survival and quality of
life.
For more detailed information on this project, please look at
the lay
summary